US Patent 7943770 Fused quinoline derivative and use thereof
Patent 7943770 was granted and assigned to Takeda Pharmaceutical Company on May, 2011 by the United States Patent and Trademark Office.
All edits
Edits on 6 Jun, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 29 Mar, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 27 Nov, 2023
Golden AI
Edits made to:
Article (+194 characters)
Article
Patent abstract
The present invention aims at provision of a quinoline derivative having a neurokinin 2 (NK2) receptor antagonistic action and relates to a compound represented by the formula (I)
Edits on 27 Sep, 2023
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 19 Sep, 2023
Golden AI
Edits made to:
Infobox (+2 properties)
Infobox
Patent Inventor Names
Masahiro Kajino0
Yasuhiko Kawano0
Edits on 21 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07943770 Fused quinoline derivative and use thereof US Patent 7943770 Fused quinoline derivative and use thereof
Infobox
Patent Number
079437700
Patent Number
79437700
Edits on 23 Sep, 2022
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
079437700
Date of Patent
May 17, 2011
0Patent Application Number
124766260
Date Filed
June 2, 2009
0Patent Primary Examiner
Edits on 7 Dec, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 07943770 Fused quinoline derivative and use thereof
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
07943770
Date of patent
May 17, 2011
Patent application number
12476626
Date Filed
June 2, 2009
Patent primary examiner
Find more entities like US Patent 7943770 Fused quinoline derivative and use thereof
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
